These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15845809)

  • 1. U.K. science. Industry-academic drug screening plan targets CJD.
    Marshall E
    Science; 2005 Apr; 308(5721):477. PubMed ID: 15845809
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid drug trial offers hope to CJD patients.
    Giles J
    Nature; 2003 Dec; 426(6966):487. PubMed ID: 14654808
    [No Abstract]   [Full Text] [Related]  

  • 3. Dapsone to delay symptoms in Creutzfeldt-Jakob disease.
    Manuelidis L; Fritch W; Zaitsev I
    Lancet; 1998 Aug; 352(9126):456. PubMed ID: 9708762
    [No Abstract]   [Full Text] [Related]  

  • 4. Compassion comes before science.
    New Sci; 2001 Aug; 171(2304):3. PubMed ID: 11838483
    [No Abstract]   [Full Text] [Related]  

  • 5. Creutzfeldt-Jakob disease and the risk from blood or blood products.
    Will RG; Kimberlin RH
    Vox Sang; 1998; 75(3):178-80. PubMed ID: 9852403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinations treated with rivastigmine in Creutzfeldt-Jakob disease.
    Chapuis C; Casez O; Lagrange E; Bedouch P; Besson G
    Fundam Clin Pharmacol; 2012 Apr; 26(2):212-4. PubMed ID: 21631588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine spongiform encephalopathy and new variant Creutzfeldt-Jakob disease: an overview.
    Patterson WJ; Painter MJ
    Commun Dis Public Health; 1999 Jan; 2(1):5-13. PubMed ID: 10462888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In search of a cure for CJD.
    Thompson C
    Nature; 2001 Feb; 409(6821):660-1. PubMed ID: 11217834
    [No Abstract]   [Full Text] [Related]  

  • 9. Quinacrine in possible or probable CJD: if you had suspected CJD would you be indifferent between placebo and quinacrine?
    Braunholtz D; Harris J
    BMJ; 2002 Jan; 324(7331):239. PubMed ID: 11809660
    [No Abstract]   [Full Text] [Related]  

  • 10. CJD researchers close to agreeing plans for first clinical trial. Arguments have marred discussions about protocol design, prompting allegations of "academic jealousy".
    Butcher J; Brown H
    Lancet; 2004 Apr; 363(9416):1201. PubMed ID: 15083817
    [No Abstract]   [Full Text] [Related]  

  • 11. UK drug company's vCJD infected drug causes chaos in Spain.
    Bosch X
    Lancet; 2001 Feb; 357(9256):618. PubMed ID: 11558499
    [No Abstract]   [Full Text] [Related]  

  • 12. Creutzfeldt-Jakob disease acquired via a dural graft: failure of therapy with quinacrine and chlorpromazine.
    Martínez-Lage JF; Rábano A; Bermejo J; Martínez Pérez M; Guerrero MC; Contreras MA; Lunar A
    Surg Neurol; 2005 Dec; 64(6):542-5, discussion 545. PubMed ID: 16293480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of variant CJD.
    Knight R
    Dev Biol (Basel); 2002; 108():87-92. PubMed ID: 12220145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Were some CJD victims infected by vaccines?
    Birmingham K
    Nature; 2000 Nov; 408(6808):3-4. PubMed ID: 11081474
    [No Abstract]   [Full Text] [Related]  

  • 15. Creutzfeldt-Jakob disease. Caring professions 'indifferent' to CJD.
    Martell R
    Nurs Times; 2000 Jul 20-26; 96(29):5. PubMed ID: 11963020
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program.
    Lim JS; Kwon HM; Jang JW; Ju YR; Kim S; Park YH; Park SY; Kim S
    Prion; 2015; 9(2):136-43. PubMed ID: 25996401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast-track CJD trial: two years late, but not derailed.
    Lancet Neurol; 2004 May; 3(5):257. PubMed ID: 15099535
    [No Abstract]   [Full Text] [Related]  

  • 18. Variant Creutzfeldt-Jakob disease.
    Will R
    Folia Neuropathol; 2004; 42 Suppl A():77-83. PubMed ID: 15449462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Creutzfeldt-Jakob disease and its therapeutic approaches].
    Sakasegawa Y; Doh-Ura K
    Nihon Rinsho; 2011 Dec; 69 Suppl 10 Pt 2():411-4. PubMed ID: 22755224
    [No Abstract]   [Full Text] [Related]  

  • 20. Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases.
    Holman RC; Khan AS; Belay ED; Schonberger LB
    Emerg Infect Dis; 1996; 2(4):333-7. PubMed ID: 8969250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.